February 2009
Bayer Pharma to Invest 100 Million Euro in China to Build a Global R&D Center
Bayer Pharma AG, the pharmaceutical division of Bayer HealthCare (BHC), announced in February 2009 that it will be strengthening its global Research and Development (R&D) capabilities through the foundation of a global R&D center in Beijing, China. The company will invest some 100 million Euro over the next five years to establish the center. With the establishment of the R&D center in China, especially Asian patients will benefit from considering their clinical profile and medical needs early-on.
